Biotech Values

[DewDiligence]

IDIX Major Shareholders

[Updated for SEC filings through 2/16/10.]


BB/MPM Capital’s holding is as of 12/31/09 (from Form 13G filed 2/16/10);
other holdings in the table are as of today. The percentages shown are based
on 71M diluted shares for valuation purposes (#msg-40353178), and hence
they differ from the percentages reported in SEC filings.

 
                      Shares   Stake 
 Novartis           31,320,964 43.7% 
 JP Sommadossi (CEO) 4,226,000* 6.0% 
 BB/MPM Capital      3,321,534  4.7% 
 GlaxoSmithKline     2,474,527  3.5% 
  
 *Includes all of Sommadossi’s 2.2M options, whether or not vested.